![Colleen Cuffaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Cuffaro
Directeur Général chez
RADD Pharmaceuticals, Inc.
Profil
Colleen Cuffaro currently works at RADD Pharmaceuticals, Inc., as President & Chief Executive Officer, New England Venture Capital Association, Inc., as Director, Arrakis Therapeutics, Inc., as Director, Comet Therapeutics, Inc., as Director, and Canaan Management, Inc., as Partner from 2020.
Dr. Cuffaro received her undergraduate degree from the University of Pennsylvania and graduate degree from Yale University.
Postes actifs de Colleen Cuffaro
| Sociétés | Poste | Début |
|---|---|---|
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Analyste en capital-investissement | 01/01/2014 |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Directeur/Membre du Conseil | - |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates trade association that encourages constructive interaction among the region's venture firms by promoting camaraderie among its members | Directeur/Membre du Conseil | - |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Directeur/Membre du Conseil | - |
RADD Pharmaceuticals, Inc.
 RADD Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops novel platform designed to address mechano-enzyme drug discovery and development | Directeur Général | - |
Formation de Colleen Cuffaro
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates trade association that encourages constructive interaction among the region's venture firms by promoting camaraderie among its members | Commercial Services |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Health Technology |
RADD Pharmaceuticals, Inc.
RADD Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops novel platform designed to address mechano-enzyme drug discovery and development | Health Technology |
